Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

[Relation between apolipoprotein CIII gene polymorphism and coronary artery disease].

Liu SK, Mu X, Yang YY, Xu Q, Wang XM, Ding RJ, Zhang ZC.

Zhonghua Yi Xue Za Zhi. 2007 Apr 24;87(16):1133-5. Chinese.

PMID:
17672999
2.

Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?

Badiou S, Garrigue V, Dupuy AM, Chong G, Cristol JP, Mourad G.

Transplant Proc. 2006 Sep;38(7):2314-6.

PMID:
16980076
3.

Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.

Tanrikulu S, Ademoglu E, Gurdol F, Mutlu-Turkoglu U, Bilge AK, Nisanci Y.

Cell Biochem Funct. 2009 Oct;27(7):452-7. doi: 10.1002/cbf.1593.

PMID:
19784962
4.

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease.

Olivieri O, Bassi A, Stranieri C, Trabetti E, Martinelli N, Pizzolo F, Girelli D, Friso S, Pignatti PF, Corrocher R.

J Lipid Res. 2003 Dec;44(12):2374-81. Epub 2003 Oct 16.

5.

Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.

Wang C, Zhou X, Ye S, Han D, Tan X, Zheng F, Shi Q.

Int J Hyg Environ Health. 2006 May;209(3):265-73. Epub 2006 Feb 3.

PMID:
16459141
6.

The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.

Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T.

Clin Biochem. 2007 Oct;40(15):1150-6. Epub 2007 Jul 6.

PMID:
17689519
7.

Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease.

Bahri R, Esteban E, Moral P, Hassine M, Ben Hamda K, Chaabani H.

Lipids Health Dis. 2008 Nov 17;7:46. doi: 10.1186/1476-511X-7-46.

8.

Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.

Barbagallo CM, Rizzo M, Noto D, Frasheri A, Pernice V, Rubino A, Pieri D, Pinto V, Cefalù AB, Giordano C, Notarbartolo A, Averna MR.

Metabolism. 2006 May;55(5):662-8.

PMID:
16631444
9.
10.
11.

Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.

Janicki K, Solski J, Janicka L, Kimak E, Bednarek-Skublewska A, Stettner S, Molas G.

Ann Univ Mariae Curie Sklodowska Med. 2004;59(1):459-66.

PMID:
16146031
12.

Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.

Duman BS, Türkoğlu C, Akpinar B, Güden M, Vertii A, Cağatay P, Günay D, Sevim Büyükdevrim A.

Ann Hum Biol. 2005 Sep-Oct;32(5):620-9.

PMID:
16316917
13.

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity.

Luo M, Liu A, Wang S, Wang T, Hu D, Wu S, Peng D.

Sci Rep. 2017 May 24;7(1):2312. doi: 10.1038/s41598-017-02601-7.

14.

Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: the Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan.

Chang PY, Lee CM, Hsu HC, Lin HJ, Chien KL, Chen MF, Chen CH, Lee YT, Yang CY.

Lipids Health Dis. 2012 Nov 23;11:162. doi: 10.1186/1476-511X-11-162.

15.

Independent association between triglycerides and coronary artery disease in Taiwanese type 2 diabetic patients.

Tseng CH, Tseng CP, Chong CK, Cheng JC, Tai TY.

Int J Cardiol. 2006 Jul 28;111(1):80-5. Epub 2005 Oct 6.

PMID:
16213608
16.

Serum lipid profiles with and without CAD: Jordan Hyperlipidaemia and Related Targets Study (JoHARTS-1).

Hammoudeh AJ, Izraiq M, Al-Mousa E, Al-Tarawneh H, Elharassis A, Mahadeen Z, Badran N, Haddad J.

East Mediterr Health J. 2008 Jan-Feb;14(1):24-32.

17.
18.

Angiotensin-I-converting enzyme (ACE) insertion/deletion polymorphism in Mexican patients with coronary artery disease. Association with the disease but not with lipid levels.

Vargas-Alarcón G, Zamora J, Sánchez-García S, Rodríguez-Pérez JM, Cardoso G, Posadas-Romero C.

Exp Mol Pathol. 2006 Oct;81(2):131-5. Epub 2006 Jun 9.

PMID:
16764852
20.

LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.

Lee SJ, Campos H, Moye LA, Sacks FM.

Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):853-8. Epub 2003 Mar 13.

PMID:
12637336

Supplemental Content

Support Center